All Products
Detailed Answer
The 2025 EAU Guidelines on Sexual and Reproductive Health do not provide specific pricing or average cost figures for penile implants. When discussing penile prosthesis implantation, the guidelines focus on medical indications, surgical techniques and outcomes rather than financial aspects.³
The total cost of a penile implant usually includes the device, the surgeon, anesthesia and the hospital or surgery center, so it varies with the type of implant, where you are treated and your health system or insurance plan. The AUA guideline notes that cost concerns can be one reason a malleable (semi-rigid) implant is chosen over an inflatable one.⁵
Inflatable vs. malleable implant cost
The type of implant is one of the things that affects the total cost. A malleable implant has no pump or reservoir, and the surgery is simpler.² ⁵ Your urologist can explain the expected costs of each type where you are treated.
Cost is also mentioned in the EAU chapter on priapism: for men who receive a penile implant after ischaemic priapism, the guidelines say the choice of implant depends on “patient suitability, surgeons’ experience, and availability and cost of the equipment.”¹
There are two main classes of penile implants: inflatable devices (two-piece and three-piece) and semi-rigid devices (malleable, mechanical and soft flexible).² The guidelines recommend considering a penile implant for men who are not suitable for other drug treatments or prefer a definitive therapy, and who do not respond to other treatments.³ They do not address insurance coverage, which differs by country and plan.
If you are considering a penile implant, discuss all available options with your urologist, who can advise on the type that best suits you; the final choice of device is made together with you.⁴ Your urologist’s office can also help you understand the expected costs and what your plan covers.
From the Guidelines
"The surgical implantation of a penile prosthesis may be considered in patients who i) are not suitable for different pharmacotherapies or prefer a definitive therapy; and, ii) do not respond to other treatment modalities." (p. 55) [3]